Marianne C. Nicolson
Aberdeen, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
Journal: EClinicalMedicine
Published: February 06, 2022
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.
Journal: Frontiers in immunology
Published: August 24, 2021
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 17, 2018
Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice.
Journal: Future oncology (London, England)
Published: July 07, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
Journal: Health technology assessment (Winchester, England)
Published: February 07, 2018
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Journal: Nature
Published: December 21, 2017
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2017
Tracking the Evolution of Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Journal: Nature
Published: January 27, 2017
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 29, 2016
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 04, 2016
Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 13, 2016
Last Updated: 09/26/2026